On this topic, a study conducted by Yakomizo et al., showed that the knockout of HMGB1 in tumor cells converted tumors from scarcely immunogenic phenotypes to inflammation-prone-ones, de facto inhibiting in vivo tumor growth. Here, HMGB1 is linked to neoplasm.